Wells Fargo
RPID icon

Wells Fargo’s Rapid Micro Biosystems RPID Stock Holding History

Wells Fargo’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-157
Closed -$152 – 7371
2024
Q1 		$152 Buy
157
+3
+2% +$3 ﹤0.01% 6565
2023
Q4 		$114 Buy
154
+8
+5% +$8 ﹤0.01% 6734
2023
Q3 		$158 Buy
146
+62
+74% +$62 ﹤0.01% 6640
2023
Q2 		$84 Buy
84
+3
+4% +$3 ﹤0.01% 6913
2023
Q1 		$106 Buy
81
+2
+3% +$3 ﹤0.01% 6923
2022
Q4 		$89 Buy
79
+2
+3% +$5 ﹤0.01% 6825
2022
Q3 		$0 Buy
77
+19
+33% +$74 ﹤0.01% 7246
2022
Q2 		$0 Sell
58
-2,858
-98% -$13.3K ﹤0.01% 7374
2022
Q1 		$20K Sell
2,916
-1,393
-32% -$10.3K ﹤0.01% 6014
2021
Q4 		$46K Sell
4,309
-95,597
-96% -$1.49M ﹤0.01% 6008
2021
Q3 		$1.84M Buy
+99,906
New +$2.06M ﹤0.01% 3736

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo's RPID Position: Q2 2024 in Review

Wells Fargo sold out of Rapid Micro Biosystems (RPID) in Q2 2024, closing a stake of 157 shares — an estimated $152 sold.

Wells Fargo first reported a position in RPID in Q3 2021 and held it in 11 quarters. The position peaked at $1.84M in Q3 2021. 21 funds tracked by Wall St. Rank hold RPID as of Q2 2024.

  • Wells Fargo reported no remaining Rapid Micro Biosystems position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 157 Rapid Micro Biosystems shares in Q2 2024, an estimated $152.
  • Wells Fargo first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 11 quarters.
  • Wells Fargo's Rapid Micro Biosystems position peaked at $1.84M in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.